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Abstract Toxins A and B from the anaerobic bacterium
Clostridium difficile are the causative agents of the antibiotic-
associated pseudomembraneous colitis. At the subcellular level,
they inhibit the Rho family GTPases, thus causing alterations of
the actin cytoskeleton. The cytoskeletal integrity is also
controlled by the redox state of cells. Therefore, we have
evaluated whether an oxidative imbalance could be involved in
the toxin-induced cytopathic effects. Our results indicate that
both toxins induce oxidative stress with a significant depletion of
protein SH-groups. These responses and the cytoskeleton-
dependent cell retraction and rounding are significantly counter-
acted by N-acetylcysteine but not by K-tocopherol. Our study
provides the first evidence that the thiol supplier N-acetylcysteine
impairs the cellular intoxication by acting on the cytoskeleton
integrity. This also suggests a possible beneficial role for this
drug during therapeutic intervention.
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1. Introduction
The anaerobic bacterium Clostridium di⁄cile has been iden-
ti¢ed as the major causative agent of antibiotic-associated
pseudomembraneous colitis [1]. It produces at least two pro-
tein toxins, the enterotoxin A (CdA) and the cytotoxin B
(CdB), both belonging to the group of intracellularly acting
bacterial proteins which have to be internalized via receptor-
mediated endocytosis to exert their cytotoxicity [2]. They are
monoglucosyltransferases which catalyze the incorporation of
glucose into the small GTP-binding proteins of the Rho fam-
ily [3,4]. Since Rho proteins are involved in the regulation of
actin assembly, such a modi¢cation renders Rho inactive, thus
provoking retraction and rounding of intoxicated cells [3,4].
This can possibly contribute to the pathogenesis of the C.
di⁄cile-associated colitis, since only toxin-producing strains
are etiologically linked to the disease.
Massive changes in the organization of the actin cytoskele-
ton such as those described above have also been reported to
be induced by an oxidative alteration of cytoskeletal thiol
groups [5,6]. Following an oxidative injury, changes in the
plasma membrane, i.e. surface blebbing, as well as in cytosolic
and nuclear components may occur as a consequence of cy-
toskeletal alterations [6,7]. Among the biological mechanisms
which counteract an oxidative injury of the cytoskeleton, a
pivotal role is played by the intracellular pool of soluble thi-
ols, most of which are represented by the reduced glutathione
(GSH).
In this paper, we report evidence that in epithelial cells both
CdA and CdB provoke a signi¢cant depletion in the GSH
levels which can be prevented by N-acetylcysteine (NAC)
but not by K-tocopherol (the most important tocopherol of
vitamin E) or its analogue trolox. Accordingly, NAC is also
e¡ective in counteracting the rounding up and the actin cy-
toskeleton breakdown which characterize the toxins’ activity.
These ¢ndings suggest a critical role for GSH levels in the
development and the progression of C. di⁄cile toxins-induced
cytopathology.
2. Materials and methods
2.1. Cells
Human epithelial HEp-2 cells and small intestine normal crypt cells
(IEC-6) were cultured at 37‡C in Dulbecco’s modi¢ed Eagle’s medium
(DMEM) supplemented with 10% fetal calf serum (Flow Laborato-
ries, Irvine, UK), 1% non-essential amino acids, 5 mM L-glutamine,
penicillin (100 U/ml), streptomycin (100 Wg/ml). Cells were subcul-
tured in 25 cm2 Falcon plastic £asks at a density of 5U104 cells/ml
and placed in a 37‡C incubator containing a 95% air 5% CO2 atmos-
phere. For IEC-6 cell cultures, insulin was added at 10 Wg/ml to the
culture medium. For morphological studies, cells were grown on glass
coverslips on separate wells and then processed for immuno£uores-
cence and scanning electron microscopy analyses as described below.
2.2. Chemicals and treatments
CdA was puri¢ed as previously described [8] and CdB was a gen-
erous gift from Christoph von Eichel-Streiber (Johannes Gutenberg-
Universitat, Mainz, Germany). 24 h after seeding, HEp-2 cells were
exposed to 3 Wg/ml of CdA or 3 ng/ml of CdB for di¡erent times as
previously described [8]. Only data obtained after 18 h of exposure to
both toxins are described in Section 3 since, under these experimental
conditions, all cells in the monolayer were rounded. After each treat-
ment, the cell viability was evaluated by a trypan blue dye exclusion
test. Anti-oxidant, NAC, [9] was purchased from Zambon Group
(Milan, Italy) and K-tocopherol [10] from Aldrich (Milwaukee, WI,
USA). In addition, trolox (Aldrich), a water soluble analogue of
K-tocopherol, was also used [11]. In order to assay the anti-oxidant
activity, NAC and trolox were directly dissolved in the culture me-
dium and added to HEp-2 cells at 10 mM for 2 h before toxins
exposure. By contrast, K-tocopherol was dissolved in DMSO and
incubated at 100 WM for 24 h before challenging cell cultures with
toxins. In this case, cells treated with an equal volume of DMSO
alone were used as controls.
2.3. Fluorescence microscopy
Following treatments, cells were ¢xed with 3.7% formaldehyde in
phosphate-bu¡ered saline solution (PBS) with 2% bovine serum albu-
min (BSA), for 10 min at room temperature. After washing in the
same bu¡er, cells were permeabilized with 0.5% Triton X-100 (Sigma
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Chemical, St. Louis, MO, USA) in PBS for 10 min at room temper-
ature. For F-actin detection, cells were stained with £uorescein-phal-
loidin (Sigma, working dilution 1:500) at 37‡C for 30 min. Finally,
after washing, coverslips were mounted with glycerol-PBS (2:1) and
analyzed with a Nikon Microphot £uorescence microscope.
2.4. Scanning electron microscopy
Control and treated cells were ¢xed with 2.5% glutaraldehyde in 0.1
M cacodylate bu¡er (pH 7.4) at room temperature for 20 min. Fol-
lowing post-¢xation in 1% OsO4 for 30 min, cells were dehydrated
through graded ethanols, critical point-dried in CO2 and gold-coated
Fig. 1. NAC prevented the CdB-induced cytoskeletal changes in epithelial cells. Scanning electron micrograph (on the left) and £uorescence mi-
crograph (on the right) of HEp-2 cells. Control cells (a, b), cells treated with NAC (c, d), cells exposed to CdB (e, f), cells pre-treated with
NAC before exposure to CdB (g, h). Bars represent 10 Wm.
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by sputtering. The samples were examined with a Cambridge 360
scanning electron microscope.
2.5. Determination of oxidized glutathione (GSSG) and GSH
To determine the total intracellular glutathione content, the enzy-
matic recycling assay with glutathione reductase (type IV, Sigma) and
5,5P-dithiobis-2-nitrobenzoic acid (DTNB, Sigma) was used, essen-
tially according to Anderson [12]. At the end of experiments, cells
were harvested, centrifuged for 5 min at 900 rpm, washed twice
with PBS, resuspended in the same bu¡er and homogenized by son-
ication for 30 s in a Soniprep 150. Cell lysates were diluted with
1 volume of 10% (w/v) ice-cold 5-sulfosalicylic acid (Sigma) and cen-
trifuged in a microfuge (6000 rpm) at 4‡C for 10 min to remove the
protein precipitate. The clear supernatants were stored at 4‡C until
assayed. Total glutathione was estimated by monitoring the formation
of chromophoric product 2-nitro-5-thiobenzoic acid at 412 nm in the
presence of glutathione reductase and NADPH. For the measurement
of GSSG, the acidi¢ed homogenates were submitted to derivatization
with undiluted 2-vinylpyridine (Aldrich) in the presence of triethanol-
amine (Sigma) for 1 h at room temperature. The amounts of both
total glutathione and GSSG in the sample were determined from a
standard curve obtained by plotting a known amount of GSH and
GSSG (both from Sigma), incubated in the respective experimental
conditions, versus the rate of the change in absorbance at 412 nm.
The amount of GSH present in the samples was calculated as the
di¡erence between total glutathione and GSSG levels. Data, expressed
as nmol of GSH or GSSG per mg of protein, were calculated on the
basis of a GSH calibration curve.
2.6. Determination of protein sulfhydryl groups and the protein content
Protein sulfhydryl groups were measured as described by Di Monte
and coworkers [13]. Cell pellets previously precipitated with ice-cold
5-sulfosalicylic acid were washed twice with 5% (w/v) of the same
solution and were ¢nally resuspended in 0.5 M Tris-HCl, pH 7.6.
DTNB (100 WM ¢nal concentration) was then added and, after
20 min, the absorbance was measured at 420 nm. Data were expressed
as nmol of SH per mg protein, calculated on the basis of a GSH
calibration curve.
The protein concentration was measured by the commercially avail-
able Coomassie brilliant blue dye-binding assay (Bio-Rad, Hercules,
CA, USA), following the manufacturer’s instructions. BSA was used
as a standard.
2.7. Statistical analysis
Each experiment was repeated at least three times and data were
presented as the mean þ S.D. Statistical signi¢cance among the groups
was determined using the unpaired two-tailed Student’s t test. A
P value 6 0.05 was taken to re£ect a signi¢cant di¡erence.
3. Results
3.1. NAC prevents cytoskeletal changes induced by C. di⁄cile
toxins in epithelial cells
Since the two toxins induced identical responses in epithe-
lial cells, only data obtained with CdB are shown here. When
observed by scanning electron microscopy, both control and
NAC-treated cells formed monolayers of spread cells adhering
well to the substrate (Figs. 1a and c, respectively). Exposure
to 3 ng of CdB per ml for 18 h caused retraction and rounding
up in the whole cell population (Fig. 1e), phenomena clearly
prevented by pre-exposure to NAC (Fig. 1g). Fluorescence
micrographs of cells stained for F-actin detection showed
the dramatic breakdown of the actin network provoked by
the toxin (Fig. 1f) which could be counteracted by NAC
pre-exposure (Fig. 1h). In accordance to our previous
reports [7], NAC alone maintained the stress ¢ber organiza-
tion (Fig. 1d) typical for control cells (Fig. 1b). By con-
trast, pre-treatment with trolox or K-tocopherol could not
prevent the toxin-induced morphological changes (data not
shown).
3.2. NAC prevents the oxidative imbalance induced by
C. di⁄cile toxins in epithelial cells
It is known that oxidative stress may be involved in several
pathways leading to cellular retraction and rounding associ-
ated to the cytoskeletal rearrangement. Also in this case, we
show only the results obtained with CdB (totally overlapping
those obtained with CdA). We observed that exposure to CdB
Fig. 2. NAC prevented the CdB-induced oxidative imbalance in epi-
thelial cells. Evaluation of the redox state of HEp-2 cells after NAC
and CdB treatments. Three di¡erent parameters have been consid-
ered in the present investigation: GSH (a), GSSG (b), protein thiol
(SH) groups (c). *P6 0.05 and **P6 0.001 versus untreated cells :
‡P6 0.05 versus CdB-treated cells.
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for 18 h provoked a signi¢cant decrease (P6 0.001) in the
intracellular GSH with respect to untreated cells (Fig. 2a),
with a concomitant 1.5-fold increase of GSSG basal levels
(P6 0.05, Fig. 2b). By contrast, when the cells were pre-
treated with 10 mM NAC for 2 h before CdB exposure, the
depletion of GSH did not appear to be e⁄ciently hindered. By
contrast, Nac exposure induced a signi¢cant reduction of
GSSG intracellular levels with respect to CdB-treated cells.
The ability of NAC to maintain the oxidative balance within
the cells was more evident evaluating the GSSG/GSH ratio,
considered to be a more precise marker of the redox potential
of the cell. In fact, while CdB-treated cells showed a severe
increase of this ratio (0.026) with respect to controls (0.009,
P6 0.001), NAC pre-treatment was able to maintain this pa-
rameter una¡ected (0.0087). Interestingly, the drop of the
GSH level due to CdB was not a cell-speci¢c phenomenon.
In fact, in IEC-6 cells, which are normal crypt cells derived
from the small intestine, CdB induced, besides an alteration of
the micro¢lament system [18], a drop of the GSH level (0.027
nmol GSH/Wg of proteins versus 0.013 nmol GSH/Wg of pro-
teins in CdB-treated cells), which was counteracted by pre-
exposure to NAC (0.035 nmol GSH/Wg of proteins in NAC-
treated cells versus 0.065 nmol GSH/Wg of proteins in NAC-
treated cells subsequently exposed to CdB).
The e¡ects of CdB exposure on the GSH homeostasis
prompted us to investigate the in£uence of treatment on pro-
tein-bound sulfhydryl groups. As shown in Fig. 2c, there was
a signi¢cant (P6 0.05) disappearance in protein thiols after
addition of 3 ng/ml of CdB to the incubation medium. By
contrast, NAC pre-treatment allows the cells to maintain their
protein thiol group pro¢le (P6 0.05 versus CdB-treated cells)
in the reduced state, the values observed being very similar to
those of controls. Hydroxyl radical scavenger agents, such as
K-tocopherol and trolox, failed in hindering such toxin-in-
duced e¡ects, i.e. cell retraction and rounding (data not
shown).
4. Discussion
Protein toxins from C. di⁄cile are important etiological
agents involved in the pathogenesis of pseudomembraneous
colitis [1]. Pathogenic strains are always toxigenic and,
although CdA is the recognized enterotoxin causing £uid se-
cretion in vivo, several lines of evidence indicate that CdB as
well plays a role in the disease [2]. In this paper, we have
reported that both toxins A and B can induce oxidative stress
in epithelial cells, notably at doses lower than those utilized to
prove monoglucosylation of Rho [3,4]. Moreover, the cellular
‘intoxication’ can be partially counteracted by those anti-ox-
idant compounds which act as thiol suppliers, such as NAC.
This drug is actually able to counteract the protein thiol
group depletion due to the toxins’ activity, maintaining the
SH-values similar to that of control cells. By contrast, radical
scavenger agents such as K-tocopherol and trolox failed in
preventing the oxidative imbalance provoked by the toxins.
This points to the requirement of SH-group supply (furnished
by NAC) to e¡ect a signi¢cant protection.
Probably, since the oxidative state of actin is critical for its
organization [14,15], the reduced state of actin, due to the
anti-oxidant activity of NAC, may ‘bu¡er’ those e¡ects
strictly dependent on cytoskeletal thiol group oxidation.
This drug could inhibit the actin ¢lament side by side cross-
linking which is typical of cell injury processes leading to
retraction, rounding and blebbing [13,16]. Thus, while an
anti-oxidant drug with a thiol supplier activity, such as
NAC, is capable of preventing (or counteracting) the toxin-
induced oxidative stress, a ‘simple’ hydroxyl radical scavenger,
such as K-tocopherol or its analog trolox, whose e¡ects are
mainly ascribable to a lipid peroxidation protection exerted at
the plasma membrane level, does not.
The drop of GSH following the challenge with both toxins
has been observed also in IEC-6 cells, normal epithelial cells
derived from rat crypt small intestine, where the two toxins
have been described to act as apoptotic inducers [17,18]. Very
little, however, is known about toxins provoking a redox im-
balance. Toxins produced by cyanobacteria, which contami-
nate water and cause serious health problems, induce an ox-
idative damage which is probably involved in cyanobacteria
extract-induced hepatotoxicity [19]. Data obtained in animals
also point to the connection between a certain enterotoxin
activity and the redox state of cells. Cholera toxin, for exam-
ple, induces £uid secretion and decreases the level of mucosal
GSH [20], although prior modulation of the thiol status of the
mucosa was ine¡ective on toxin-induced £uid secretion. This
is in accordance with our ¢ndings showing that also CdB,
which is involved in the disease but does not cause £uid se-
cretion, is capable of altering the oxidative state of the cells.
In conclusion, taken together, all the above reported results
clearly indicate that C. di⁄cile toxins cause oxidative imbal-
ance in epithelial cells which can be counteracted by anti-
oxidant compounds acting as thiol suppliers, such as NAC.
A role for NAC as an anti-dote for poisoning has already
been reported [21]. Hence, the observation that certain bacte-
rial toxins acting as enteropathogenic virulence factors pro-
voke oxidative stress in cells is a new point of view which may
provide some clues to the pharmacological control of their
intoxication-associated cytopathology.
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